The anchorage-independence of cells is closely related to their tumorigenicity. In the screening of inhibitors of anchorage-independent growth of tumor cells, anicemycin was isolated from the fermentation broth of an actinomycete strain TP-A0648. The producing strain was isolated from a leaf of Aucuba japonica collected in Toyama, Japan and identified as Streptomyces sp. based on the taxonomic data. The structure of anicemycin was elucidated as a new analog of spicamycin by NMR and MS analysis. Anicemycin inhibited the anchorage-independent growth of the human ovary cancer SKOV-3 cells with an IC 50 of 0.015 mM about three times more potently than their anchorage-dependent growth.Keywords anicemycin, anchorage-independent growth, cytotoxic, spicamycin, Streptomyces
IntroductionMost of the previously developed antitumor agents act mainly on the nucleic acid biosynthesis, DNA or microtubules and therefore these agents show cytotoxicity to normal tissues with significant adverse effects. Recent researches on the mechanism of cancer have been disclosing that a number of oncogenes are involved in tumorigenesis and many of these gene products are functioning as signal transduction molecules. The agents that inhibit the signal transduction of oncogenes are expected to become selective and safe anticancer drugs [1].The normal cells derived from epithelial and endothelial cells can proliferate only when they attach to the firm substrate. When these cells detach from the substrate and lose contact with the matrix, they die in an apoptotic process termed 'anoikis'. On the other hand, cancer cells usually have developed resistance to anoikis and show growth ability without the firm substrate attachment, namely the anchorage-independence. Cell viability under anchorage-dependent conditions is regulated by integrin signal transduction through its interaction with the extracellular matrix. Various oncogenes expressed in transformed and cancer cells cause constitutive activation of the integrin signaling pathway which results in anoikis resistance [2,3].In our screening program of new antitumor compounds from microbial secondary metabolites, anicemycin (Fig. 1) was isolated as an inhibitor of anchorage-independent growth from Streptomyces sp. TP-A0648. In this paper, we describe the fermentation, isolation, structure and biological activity of anicemycin.
Materials and Methods
General Experimental ProceduresNMR experiments were performed on a JEOL JNM-LA400 NMR spectrometer. The MS spectra were measured on a JEOL JMS-HX110A spectrometer. UV spectra were